2157-9024

Oncogenesis

Springer Science and Business Media LLC

View prefix report (10.1038)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 483 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact483 DOIs
2

Add abstracts to 242 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact242 DOIs
3

Deposit reference lists for 60 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact60 DOIs

DOIs for this ISSN

Showing the top 5 of 1006 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Epigenetic and genetic features of 24 colon cancer cell line… (10.1038/oncsis.2013.35)
Abstract ORCID
144.58 778
2 SOX2 promotes dedifferentiation and imparts stem cell-like f… (10.1038/oncsis.2013.23)
Abstract ORCID
120.83 260
3 A mechanism of resistance to gefitinib mediated by cellular… (10.1038/oncsis.2013.4)
Abstract ORCID
115.16 200
4 Enteric bacterial protein AvrA promotes colonic tumorigenesi… (10.1038/oncsis.2014.20)
Abstract ORCID
112.28 175
5 Erratum: Meta-analysis of the global gene expression profile… (10.1038/oncsis.2014.41)
Abstract References ORCID
108.54 27
6 MUC1 induces drug resistance in pancreatic cancer cells via… (10.1038/oncsis.2013.16)
Abstract ORCID
107.15 138
7 Identification of LDH-A as a therapeutic target for cancer c… (10.1038/oncsis.2014.16)
Abstract ORCID
103.22 115
8 Deubiquitination of Dishevelled by Usp14 is required for Wnt… (10.1038/oncsis.2013.28)
Abstract ORCID
102.65 112
9 DNA replication stress response involving PLK1, CDC6, POLQ,… (10.1038/oncsis.2012.29)
Abstract ORCID
100.64 102
10 Downregulation of miRNA-31 induces taxane resistance in ovar… (10.1038/oncsis.2013.3)
Abstract ORCID
100.22 100
11 Involvement of polypyrimidine tract-binding protein (PTBP1)… (10.1038/oncsis.2013.47)
Abstract ORCID
99.78 98
12 MicroRNA-18a is elevated in prostate cancer and promotes tum… (10.1038/oncsis.2014.12)
Abstract ORCID
99.56 97
13 NVP-LDE-225 (Erismodegib) inhibits epithelial–mesenchymal tr… (10.1038/oncsis.2013.5)
Abstract ORCID
98.89 94
14 MicroRNA-203 functions as a tumor suppressor in basal cell c… (10.1038/oncsis.2012.3)
Abstract ORCID
97.22 87
15 Selective CREB-dependent cyclin expression mediated by the P… (10.1038/oncsis.2014.21)
Abstract ORCID
97.22 87
16 Binding of αvβ1 and αvβ6 integrins to tenascin-C induces epi… (10.1038/oncsis.2013.27)
Abstract ORCID
96.98 86
17 Deregulation of let-7e in epithelial ovarian cancer promotes… (10.1038/oncsis.2013.39)
Abstract ORCID
95.69 81
18 Expression, regulation and clinical relevance of the ATPase… (10.1038/oncsis.2013.9)
Abstract ORCID
95.42 80
19 Activation of the AKT/cyclin D1/Cdk4 survival signaling path… (10.1038/oncsis.2012.12)
Abstract ORCID
93.17 72
20 Suppression of SCARA5 by Snail1 is essential for EMT-associa… (10.1038/oncsis.2013.37)
Abstract ORCID
92.87 71
21 Strong EGFR signaling in cell line models of ERBB2-amplified… (10.1038/oncsis.2012.16)
Abstract ORCID
92.56 70
22 Accumulation of abasic sites induces genomic instability in… (10.1038/oncsis.2014.42)
Abstract ORCID
92.25 69
23 Overexpression of ETV4 is oncogenic in prostate cells throug… (10.1038/oncsis.2012.20)
Abstract ORCID
90.98 65
24 Genomic copy number alterations in clear cell renal carcinom… (10.1038/oncsis.2012.14)
Abstract ORCID
90.65 64
25 Tumor suppressor NDRG2 tips the balance of oncogenic TGF-β v… (10.1038/oncsis.2013.48)
Abstract ORCID
90.65 64
26 Frequent MYC coamplification and DNA hypomethylation of mult… (10.1038/oncsis.2014.8)
Abstract ORCID
90.31 63
27 LSD1 controls metastasis of androgen-independent prostate ca… (10.1038/oncsis.2014.34)
Abstract ORCID
89.27 60
28 Meta-analysis of the global gene expression profile of tripl… (10.1038/oncsis.2014.14)
Abstract ORCID
88.91 59
29 Expression of PIK3CA mutant E545K in the mammary gland induc… (10.1038/oncsis.2013.38)
Abstract ORCID
87.79 56
30 PSGR promotes prostatic intraepithelial neoplasia and prosta… (10.1038/oncsis.2014.29)
Abstract ORCID
87.79 56
31 MiRNA-99a directly regulates AGO2 through translational repr… (10.1038/oncsis.2014.11)
Abstract ORCID
87.02 54
32 Crosstalk between PKCα and Notch-4 in endocrine-resistant br… (10.1038/oncsis.2013.26)
Abstract ORCID
86.21 52
33 Retinoic acid represses invasion and stem cell phenotype by… (10.1038/oncsis.2013.6)
Abstract ORCID
86.21 52
34 S100P antibody-mediated therapy as a new promising strategy… (10.1038/oncsis.2014.7)
Abstract ORCID
86.21 52
35 Erratum: MiR-125a promotes paclitaxel sensitivity in cervica… (10.1038/oncsis.2016.21)
Abstract References ORCID
85.96 13
36 Serum-stimulated cell cycle entry promotes ncOGT synthesis r… (10.1038/oncsis.2012.36)
Abstract ORCID
85.80 51
37 Methylation profile of triple-negative breast carcinomas (10.1038/oncsis.2012.17)
Abstract ORCID
85.38 50
38 More targets, more pathways and more clues for mutant p53 (10.1038/oncsis.2013.15)
Abstract ORCID
85.38 50
39 A mesenchymal glioma stem cell profile is related to clinica… (10.1038/oncsis.2014.5)
Abstract ORCID
85.38 50
40 Membranous Nectin-4 expression is a risk factor for distant… (10.1038/oncsis.2014.32)
Abstract ORCID
84.51 48
41 DNA-PKcs activates the Chk2–Brca1 pathway during mitosis to… (10.1038/oncsis.2013.49)
Abstract ORCID
84.06 47
42 Selective repression of the oncogene cyclin D1 by the tumor… (10.1038/oncsis.2014.26)
Abstract ORCID
83.60 46
43 Glioblastoma cells inhibit astrocytic p53-expression favorin… (10.1038/oncsis.2014.36)
Abstract ORCID
83.60 46
44 Overexpression of miR-26a-2 in human liposarcoma is correlat… (10.1038/oncsis.2013.10)
Abstract ORCID
83.14 45
45 Periostin cooperates with mutant p53 to mediate invasion thr… (10.1038/oncsis.2013.17)
Abstract ORCID
83.14 45
46 Centrosomal kinase Nek2 cooperates with oncogenic pathways t… (10.1038/oncsis.2013.34)
Abstract ORCID
83.14 45
47 The Yes-associated protein controls the cell density regulat… (10.1038/oncsis.2014.27)
Abstract ORCID
83.14 45
48 The tumor suppressor RASSF10 is upregulated upon contact inh… (10.1038/oncsis.2012.18)
Abstract ORCID
82.17 43
49 MicroRNAs in colorectal cancer stem cells: new regulators of… (10.1038/oncsis.2012.33)
Abstract ORCID
82.17 43
50 Epigenetic silencing of monoallelically methylated miRNA loc… (10.1038/oncsis.2013.21)
Abstract ORCID
82.17 43